Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma. - Lu Z; Shi H; Gao R; Zhong C; Zhang W; Zhu J; Huang J; Liu R; Xing Y; Chu Y; Sun H; Shi G; et al. (Nature communications, 2025)